Exploring the potential benefits of pharmacogenomics in chronic respiratory diseases

Pharmacogenomics. 2023 Apr;24(5):239-241. doi: 10.2217/pgs-2023-0036. Epub 2023 Apr 4.

Abstract

Tweetable abstract Opportunities for pharmacogenetics implementation in chronic respiratory diseases through the employment of genotype-guided prescriptions in treating nonrespiratory comorbidities.

Keywords: anticoagulants; asthma; chronic obstructive pulmonary disease; pharmacogenomics; smoking; statins.

Publication types

  • Editorial

MeSH terms

  • Genotype
  • Humans
  • Pharmacogenetics*
  • Respiratory Tract Diseases* / drug therapy
  • Respiratory Tract Diseases* / genetics